165 related articles for article (PubMed ID: 9304411)
21. Relationship between bioavailability and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats.
Uchida T; Aoyama K; Watanabe T; Higuchi S
Atherosclerosis; 1998 Mar; 137(1):97-106. PubMed ID: 9568741
[TBL] [Abstract][Full Text] [Related]
22. Acyl CoA:cholesterol acyltransferase (ACAT) inhibitors: synthesis and structure-activity relationship studies of a new series of trisubstituted imidazoles.
Higley CA; Wilde RG; Maduskuie TP; Johnson AL; Pennev P; Billheimer JT; Robinson CS; Gillies PJ; Wexler RR
J Med Chem; 1994 Oct; 37(21):3511-22. PubMed ID: 7932580
[TBL] [Abstract][Full Text] [Related]
23. Effects of acyl-CoA: cholesterol O-acyltransferase inhibition on cholesterol absorption and plasma lipoprotein composition in hamsters.
Schnitzer-Polokoff R; Compton D; Boykow G; Davis H; Burrier R
Comp Biochem Physiol A Comp Physiol; 1991; 99(4):665-70. PubMed ID: 1679704
[TBL] [Abstract][Full Text] [Related]
24. Studies on acyl-CoA: cholesterol acyltransferase (ACAT) inhibitory effects and enzyme selectivity of F-1394, a pantotheic acid derivative.
Kusunoki J; Aragane K; Yamaura T; Ohnishi H
Jpn J Pharmacol; 1995 Mar; 67(3):195-203. PubMed ID: 7630037
[TBL] [Abstract][Full Text] [Related]
25. Effect of the ACAT inhibitor, HL-004, on cholesterol metabolism in macrophages.
Murakami S; Yamagishi I; Asami Y; Sato M; Tomisawa K
Cell Mol Biol (Noisy-le-grand); 1996 Sep; 42(6):865-72. PubMed ID: 8891354
[TBL] [Abstract][Full Text] [Related]
26. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
[TBL] [Abstract][Full Text] [Related]
27. Effects of F-1394, an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on ACAT activity in HepG2 cells and on hepatic secretion of lipids in Triton WR-1339-induced hyperlipidemic rats: possible role of hepatic ACAT in very low density lipoprotein secretion.
Aragane K; Kusunoki J; Kitamine T; Yamaura T; Ohnishi H
Jpn J Pharmacol; 1998 Mar; 76(3):309-12. PubMed ID: 9593225
[TBL] [Abstract][Full Text] [Related]
28. Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis.
Perrey S; Legendre C; Matsuura A; Guffroy C; Binet J; Ohbayashi S; Tanaka T; Ortuno JC; Matsukura T; Laugel T; Padovani P; Bellamy F; Edgar AD
Atherosclerosis; 2001 Apr; 155(2):359-70. PubMed ID: 11254906
[TBL] [Abstract][Full Text] [Related]
29. Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Synthesis and hypocholesterolemic activity of dibenz[b,e]oxepin-11-carboxanilides.
Kumazawa T; Yanase M; Harakawa H; Obase H; Shirakura S; Ohishi E; Oda S; Kubo K; Yamada K
J Med Chem; 1994 Mar; 37(6):804-10. PubMed ID: 8145231
[TBL] [Abstract][Full Text] [Related]
30. Polyunsaturated fatty acid anilides as inhibitors of acyl-coA: cholesterol acyltransferase (ACAT).
Matsuyama N; Kosaka T; Fukuhara M; Soda Y; Mizuno K
Bioorg Med Chem Lett; 1999 Jul; 9(14):2039-42. PubMed ID: 10450977
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationships of N-(3,5-dimethoxy-4-n-octyloxycinnamoyl)-N'-(3,4-dimethylphenyl)piperazine and analogues as inhibitors of acyl-CoA: cholesterol O-acyltransferase.
Ohishi K; Aiyama R; Hatano H; Yoshida Y; Wada Y; Yokoi W; Sawada H; Watanabe T; Yokokura T
Chem Pharm Bull (Tokyo); 2001 Jul; 49(7):830-9. PubMed ID: 11456087
[TBL] [Abstract][Full Text] [Related]
32. A selective inhibitor of intestinal ACAT, EAB309 suppresses both intestinal and hepatic cholesterol output and stimulates chylomicron removal.
Umeda Y; Hirano T; Kako Y; Kamagata K; Okuyama K; Suzuki K
Life Sci; 1998; 63(13):PL187-95. PubMed ID: 9763214
[TBL] [Abstract][Full Text] [Related]
33. Acyl-CoA:cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.
Harris NV; Smith C; Ashton MJ; Bridge AW; Bush RC; Coffee EC; Dron DI; Harper MF; Lythgoe DJ; Newton CG
J Med Chem; 1992 Nov; 35(23):4384-92. PubMed ID: 1447739
[TBL] [Abstract][Full Text] [Related]
34. Effect of the ACAT inhibitor CI-976 on plasma cholesterol concentrations and distribution in hamsters fed zero- and low-cholesterol diets.
Krause BR; Bousley RF; Kieft KA; Stanfield RL
Clin Biochem; 1992 Oct; 25(5):371-7. PubMed ID: 1490301
[TBL] [Abstract][Full Text] [Related]
35. Acyl-CoA: cholesterol acyltransferase inhibitory activity of ginseng sapogenins, produced from the ginseng saponins.
Kwon BM; Kim MK; Baek NI; Kim DS; Park JD; Kim YK; Lee HK; Kim SI
Bioorg Med Chem Lett; 1999 May; 9(10):1375-8. PubMed ID: 10360739
[TBL] [Abstract][Full Text] [Related]
36. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
Takahashi K; Kunishiro K; Kasai M; Miike T; Kurahashi K; Shirahase H
Arzneimittelforschung; 2008; 58(12):666-72. PubMed ID: 19202739
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of acyl CoA:cholesterol acyltransferase.
Vaccaro W; Amore C; Berger J; Burrier R; Clader J; Davis H; Domalski M; Fevig T; Salisbury B; Sher R
J Med Chem; 1996 Apr; 39(8):1704-19. PubMed ID: 8648610
[TBL] [Abstract][Full Text] [Related]
38. Dietary cholesterol fails to stimulate acylcoenzyme A: cholesterol acyltransferase activity in the liver of hamsters with a spontaneous high level of cholesterol.
Sicart R; Sablé-Amplis R
Ann Nutr Metab; 1992; 36(2):61-70. PubMed ID: 1510348
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Huff MW
Biochim Biophys Acta; 1998 Jul; 1393(1):63-79. PubMed ID: 9714740
[TBL] [Abstract][Full Text] [Related]
40. TMP-153, a novel ACAT inhibitor, lowers plasma cholesterol through its hepatic action in golden hamsters.
Sugiyama Y; Odaka H; Itokawa S; Ishikawa E; Tomari Y; Ikeda H
Atherosclerosis; 1995 Nov; 118(1):145-53. PubMed ID: 8579624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
